Stilley William B. III 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Aug 23, 2022
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Options
2022-08-22+100,000→ 100,000 totalExercise: $0.56From: 2022-09-01Exp: 2032-08-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted.